Masahiro Aoki
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Immunology top 5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Peter K. VogtTeruaki FujishitaMakoto M. TaketoBing‐Hua JiangJenny Z. ZhengPhilip N. TsichlisAlfonso BellacosaHao Jiang
- Topics
- PI3K/AKT/mTOR signaling in cancer (15 papers)Cancer, Hypoxia, and Metabolism (7 papers)Wnt/β-catenin signaling in development and cancer (7 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Masahiro Aoki
71 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 3.6k
- Oncology 1.3k
- Cancer Research 824
- Immunology 752
- Pathology and Forensic Medicine 509
Countries citing papers authored by Masahiro Aoki
This map shows the geographic impact of Masahiro Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Aoki more than expected).
Fields of papers citing papers by Masahiro Aoki
This network shows the impact of papers produced by Masahiro Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Aoki. The network helps show where Masahiro Aoki may publish in the future.
Co-authorship network of co-authors of Masahiro Aoki
This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Aoki. A scholar is included among the top collaborators of Masahiro Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Aoki. Masahiro Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 36 | |
| 3 | 4 | |
| 4 | 17 | |
| 5 | 21 | |
| 6 | 45 | |
| 7 | 51 | |
| 8 | 24 | |
| 9 | 6 | |
| 10 | 22 | |
| 11 | 1 | |
| 12 | 30 | |
| 13 | 33 | |
| 14 | 51 | |
| 15 | 135 | |
| 16 | 234 | |
| 17 | 77 | |
| 18 | 1 | |
| 19 | 7 | |
| 20 | 5 |
About Masahiro Aoki
Masahiro Aoki is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cancer Research, having authored 71 papers that have together received 4.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). The work is most often cited by research in Cancer Research (824 citations), Molecular Biology (3.6k citations) and Aging (87 citations). Masahiro Aoki has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Peter K. Vogt, Teruaki Fujishita, Makoto M. Taketo, Bing‐Hua Jiang, Jenny Z. Zheng, Philip N. Tsichlis, Alfonso Bellacosa, Hao Jiang, Masanobu Oshima and Takanori Kitamura. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.